|
|
||||||||
CUTTING EDGE |
Carlos and Marguerite Mason Transplantation Biology Research Center, Department of Surgery, Emory University School of Medicine, Atlanta, GA 30322
Transplantation tolerance, defined as allograft acceptance by an immunocompetent recipient in the absence of long-term immunosuppression, has remained an elusive goal in clinical transplantation. Robust experimental tolerance induction strategies have in common methods to induce mixed hemopoietic chimerism. To date, however, chimerism induction across allogeneic barriers has required recipient conditioning with irradiation or cytoablative agents. In this paper we show that B6 recipients of fully allogeneic BALB/c skin grafts treated with repeated doses of donor bone marrow and anti-CD40 ligand (CD40L) develop durable (>300 days), readily detectable (612%) multilineage hemopoietic chimerism, indefinite allograft acceptance (>300 days), and donor-specific tolerance to secondary skin grafts. Analysis of the TCR repertoire of treated mice indicates that the underlying mechanisms of tolerance are in part mediated by deletion of donor-reactive T cells. These data demonstrate that durable hemopoietic chimerism and robust transplantation tolerance can be achieved without cytotoxic conditioning using a potentially clinically applicable regimen.
This article has been cited by other articles:
![]() |
D. M. Miller, T. B. Thornley, T. Pearson, A. J. Kruger, M. Yamazaki, L. D. Shultz, R. M. Welsh, M. A. Brehm, A. A. Rossini, and D. L. Greiner TLR Agonists Prevent the Establishment of Allogeneic Hematopoietic Chimerism in Mice Treated with Costimulation Blockade J. Immunol., May 1, 2009; 182(9): 5547 - 5559. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kurtz, F. Raval, C. Vallot, J. Der, and M. Sykes CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance Blood, April 9, 2009; 113(15): 3475 - 3484. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xu, J. Yan, Y. Huang, P. M. Chilton, C. Ding, C. L. Schanie, L. Wang, and S. T. Ildstad Costimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization Blood, March 15, 2008; 111(6): 3266 - 3275. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Koehn, M. A. Williams, K. Borom, S. Gangappa, T. C. Pearson, R. Ahmed, and C. P. Larsen Fully MHC-Disparate Mixed Hemopoietic Chimeras Show Specific Defects in the Control of Chronic Viral Infections J. Immunol., August 15, 2007; 179(4): 2616 - 2626. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Westerhuis, W. G. E. Maas, R. Willemze, R. E. M. Toes, and W. E. Fibbe Long-term mixed chimerism after immunologic conditioning and MHC-mismatched stem-cell transplantation is dependent on NK-cell tolerance Blood, September 15, 2005; 106(6): 2215 - 2220. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Domenig, A. Sanchez-Fueyo, J. Kurtz, S. P. Alexopoulos, C. Mariat, M. Sykes, T. B. Strom, and X. X. Zheng Roles of Deletion and Regulation in Creating Mixed Chimerism and Allograft Tolerance Using a Nonlymphoablative Irradiation-Free Protocol J. Immunol., July 1, 2005; 175(1): 51 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Metzler, P. Gfeller, M. Bigaud, J. Li, G. Wieczorek, C. Heusser, P. Lake, and A. Katopodis Combinations of Anti-LFA-1, Everolimus, Anti-CD40 Ligand, and Allogeneic Bone Marrow Induce Central Transplantation Tolerance through Hemopoietic Chimerism, Including Protection from Chronic Heart Allograft Rejection J. Immunol., December 1, 2004; 173(11): 7025 - 7036. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Waldmann and S. Cobbold Exploiting Tolerance Processes in Transplantation Science, July 9, 2004; 305(5681): 209 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Graca, A. Le Moine, C.-Y. Lin, P. J. Fairchild, S. P. Cobbold, and H. Waldmann Donor-specific transplantation tolerance: The paradoxical behavior of CD4+CD25+ T cells PNAS, July 6, 2004; 101(27): 10122 - 10126. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Boulday, J. Ashton-Chess, P. Bernard, G. Karam, H. Vie, A. Moreau, D. Minault, K. Lorre, J.-P. Soulillou, and G. Blancho Association of rapamycin and co-stimulation blockade using anti-B7 antibodies in renal allotransplantation in baboons Nephrol. Dial. Transplant., July 1, 2004; 19(7): 1752 - 1760. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kurtz, J. Shaffer, A. Lie, N. Anosova, G. Benichou, and M. Sykes Mechanisms of early peripheral CD4 T-cell tolerance induction by anti-CD154 monoclonal antibody and allogeneic bone marrow transplantation: evidence for anergy and deletion but not regulatory cells Blood, June 1, 2004; 103(11): 4336 - 4343. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ito, Y. Takeuchi, J. Shaffer, and M. Sykes Local irradiation enhances congenic donor pluripotent hematopoietic stem cell engraftment similarly in irradiated and nonirradiated sites Blood, March 1, 2004; 103(5): 1949 - 1954. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Kean, E. A. Manci, J. Perry, C. Balkan, S. Coley, D. Holtzclaw, A. B. Adams, C. P. Larsen, L. L. Hsu, and D. R. Archer Chimerism and cure: hematologic and pathologic correction of murine sickle cell disease Blood, December 15, 2003; 102(13): 4582 - 4593. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Soper, M. D. Lessard, C. D. Jude, A. J. T. Schuldt, R. M. Bunte, and J. E. Barker Successful Allogeneic Neonatal Bone Marrow Transplantation Devoid of Myeloablation Requires Costimulatory Blockade J. Immunol., September 15, 2003; 171(6): 3270 - 3277. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Blaha, S. Bigenzahn, Z. Koporc, M. Schmid, F. Langer, E. Selzer, H. Bergmeister, F. Wrba, J. Kurtz, C. Kiss, et al. The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade Blood, April 1, 2003; 101(7): 2886 - 2893. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Williams, A. B. Adams, M. B. Walsh, N. Shirasugi, T. M. Onami, T. C. Pearson, R. Ahmed, and C. P. Larsen Primary and Secondary Immunocompetence in Mixed Allogeneic Chimeras J. Immunol., March 1, 2003; 170(5): 2382 - 2389. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xu, S. P. Montgomery, E. H. Preston, D. K. Tadaki, D. A. Hale, D. M. Harlan, and A. D. Kirk Studies Investigating Pretransplant Donor-Specific Blood Transfusion, Rapamycin, and the CD154-Specific Antibody IDEC-131 in a Nonhuman Primate Model of Skin Allotransplantation J. Immunol., March 1, 2003; 170(5): 2776 - 2782. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Yin, N. Dujovny, L. Ma, A. Varghese, J. Shen, D. K. Bishop, and A. S. Chong IFN-{gamma} Production Is Specifically Regulated by IL-10 in Mice Made Tolerant with Anti-CD40 Ligand Antibody and Intact Active Bone J. Immunol., January 15, 2003; 170(2): 853 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Williams, T. M. Onami, A. B. Adams, M. M. Durham, T. C. Pearson, R. Ahmed, and C. P. Larsen Cutting Edge: Persistent Viral Infection Prevents Tolerance Induction and Escapes Immune Control Following CD28/CD40 Blockade-Based Regimen J. Immunol., November 15, 2002; 169(10): 5387 - 5391. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Taylor, C. J. Lees, J. M. Wilson, M. J. Ehrhardt, M. T. Campbell, R. J. Noelle, and B. R. Blazar Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions Blood, October 16, 2002; 100(9): 3400 - 3407. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Brenner, T. H. Tung, J. N. Jensen, and S. E. Mackinnon The Spectrum of Complications of Immunosuppression: Is the Time Right for Hand Transplantation? J. Bone Joint Surg. Am., October 10, 2002; 84(10): 1861 - 1870. [Full Text] [PDF] |
||||
![]() |
M. Eto, H. Hackstein, K. Kaneko, K. Nomoto, and A. W. Thomson Promotion of Skin Graft Tolerance Across MHC Barriers by Mobilization of Dendritic Cells in Donor Hemopoietic Cell Infusions J. Immunol., September 1, 2002; 169(5): 2390 - 2396. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shirasugi, A. B. Adams, M. M. Durham, A. E. Lukacher, H. Xu, P. Rees, S. R. Cowan, M. A. Williams, T. C. Pearson, and C. P. Larsen Prevention of Chronic Rejection in Murine Cardiac Allografts: A Comparison of Chimerism- and Nonchimerism-Inducing Costimulation Blockade-Based Tolerance Induction Regimens J. Immunol., September 1, 2002; 169(5): 2677 - 2684. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Forman, R. M. Welsh, T. G. Markees, B. A. Woda, J. P. Mordes, A. A. Rossini, and D. L. Greiner Viral Abrogation of Stem Cell Transplantation Tolerance Causes Graft Rejection and Host Death by Different Mechanisms J. Immunol., June 15, 2002; 168(12): 6047 - 6056. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Kean, M. M. Durham, A. B. Adams, L. L. Hsu, J. R. Perry, D. Dillehay, T. C. Pearson, E. K. Waller, C. P. Larsen, and D. R. Archer A cure for murine sickle cell disease through stable mixed chimerism and tolerance induction after nonmyeloablative conditioning and major histocompatibility complex-mismatched bone marrow transplantation Blood, March 1, 2002; 99(5): 1840 - 1849. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yamada, A. D. Salama, and M. H. Sayegh The Role of Novel T Cell Costimulatory Pathways in Autoimmunity and Transplantation J. Am. Soc. Nephrol., February 1, 2002; 13(2): 559 - 575. [Full Text] [PDF] |
||||
![]() |
N. N. Iwakoshi, T. G. Markees, N. Turgeon, T. Thornley, A. Cuthbert, J. Leif, N. E. Phillips, J. P. Mordes, D. L. Greiner, and A. A. Rossini4 Skin Allograft Maintenance in a New Synchimeric Model System of Tolerance J. Immunol., December 1, 2001; 167(11): 6623 - 6630. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Williams, J. T. Tan, A. B. Adams, M. M. Durham, N. Shirasugi, J. K. Whitmire, L. E. Harrington, R. Ahmed, T. C. Pearson, and C. P. Larsen Characterization of Virus-Mediated Inhibition of Mixed Chimerism and Allospecific Tolerance J. Immunol., November 1, 2001; 167(9): 4987 - 4995. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Adams, M. M. Durham, L. Kean, N. Shirasugi, J. Ha, M. A. Williams, P. A. Rees, M. C. Cheung, S. Mittelstaedt, A. W. Bingaman, et al. Costimulation Blockade, Busulfan, and Bone Marrow Promote Titratable Macrochimerism, Induce Transplantation Tolerance, and Correct Genetic Hemoglobinopathies with Minimal Myelosuppression J. Immunol., July 15, 2001; 167(2): 1103 - 1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Taylor, C. J. Lees, H. Waldmann, R. J. Noelle, and B. R. Blazar Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions Blood, July 15, 2001; 98(2): 467 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Taylor, R. J. Noelle, and B. R. Blazar Cd4+Cd25+ Immune Regulatory Cells Are Required for Induction of Tolerance to Alloantigen via Costimulatory Blockade J. Exp. Med., June 4, 2001; 193(11): 1311 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Williams, J. Trambley, J. Ha, A. B. Adams, M. M. Durham, P. Rees, S. R. Cowan, T. C. Pearson, and C. P. Larsen Genetic Characterization of Strain Differences in the Ability to Mediate CD40/CD28-Independent Rejection of Skin Allografts J. Immunol., December 15, 2000; 165(12): 6849 - 6857. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pugin, M.-C. Widmer, S. Kossodo, C.-M. Liang, H. L. Preas II, and A. F. Suffredini Human Neutrophils Secrete Gelatinase B In Vitro and In Vivo in Response to Endotoxin and Proinflammatory Mediators Am. J. Respir. Cell Mol. Biol., March 1, 1999; 20(3): 458 - 464. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |